Biomarkers of Injectable Extended Release Naltrexone Treatment
NCT02324725
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
32
Enrollment
OTHER
Sponsor class
Conditions
Heroin Dependence
Opioid Dependence
Interventions
DRUG:
Naltrexone
Sponsor
University of Pennsylvania